share_log

Larimar Therapeutics | 8-K: Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results

SEC ·  Nov 10, 2022 07:01
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more